Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery

被引:15
|
作者
Li, Changhui [1 ]
Shen, Yinchen [1 ]
Hu, Fang [1 ]
Chu, Tianqing [1 ]
Yang, Xiaohua [2 ]
Shao, Jinchen [3 ]
Zheng, Xiaoxuan [1 ]
Xu, Jianlin [1 ]
Zhang, Hai [1 ]
Han, Baohui [1 ]
Zhong, Hua [1 ]
Zhang, Xueyan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Cent Lab, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pathol, 241 West HuaihaiRd, Shanghai 200030, Peoples R China
关键词
Lung adenocarcinoma; EGFR; Micropapillary; Brain metastases; Surgical resection; HISTOLOGIC SUBTYPE; CANCER PATIENTS; CLASSIFICATION; PROGNOSIS; IMPACT; CHEMOTHERAPY; RISK;
D O I
10.1016/j.lungcan.2020.01.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The role of micropapillary pattern (MIP) in EGFR-mutated NSCLC patients with brain metastases (BM) after complete surgical resection still remains unclear. Therefore, a retrospective study was conducted to evaluate the role of MIP in those patients. Methods: This study included 332 stage I-III patients with EGFR-mutant lung adenocarcinoma and complete resection. Patients were classified in four groups: the MIP-positive patients without BM development, the MIP-negative patients without BM development, the MIP-positive patients with BM development and the MIP-negative patients with BM development. Intracranial disease-free survival (iDFS), systemic disease-free survival (DFS) and overall survival (OS) were evaluated. Results: The median OS in the whole group was 70 months. The patients with MIP show inferior DFS (13 months vs. 22 months; P < 0.001) and OS (56 months vs. 74 months; P < 0.001). Furthermore, BM development was more likely to be found in patients with MIP (P = 0.001). In addition, the MIP-positive patients showed a significantly shorter iDFS compared with MIP-negative patients (14.5 months vs. 26 months; P < 0.001). Furthermore, the MIP-positive patients had significantly inferior iDFS in both BM as first line development groups (13 months vs. 19 months; P < 0.001) and BM as non-first line development groups (18 months vs. 33 months; P = 0.007). Conclusions: MIP was related to the earlier recurrence and shortened survival time. In addition, MIP was an independent poor prognostic factor for the increase of BM rate and the shortened time of BM development after surgery.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 50 条
  • [41] Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases
    Li, Yibin
    Guo, Weixi
    Jiang, Bin
    Han, Chengkun
    Ye, Feng
    Wu, Jingxun
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Glycodelin As A Biomarker Of Advanced Lung Adenocarcinoma Brain Metastases In Patients Treated With EGFR Tyrosine Kinase Inhibitors
    Ni, Zexu
    Zhang, Lingling
    Zheng, Jinhua
    Su, Xiaojie
    Zhang, Shucai
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9421 - 9425
  • [43] The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases
    Sperduto, Paul W.
    Yang, T. Jonathan
    Beal, Kathryn
    Pan, Hubert
    Brown, Paul D.
    Bangdiwala, Ananta
    Shanley, Ryan
    Yeh, Norman
    Gaspar, Laurie E.
    Braunstein, Steve
    Gaspar, Laurie E.
    Braunstein, Steve
    Sneed, Penny
    Boyle, John
    Kirkpatrick, John P.
    Mak, Kimberley S.
    Shih, Helen A.
    Engelman, Alex
    Roberge, David
    Arvold, Nils D.
    Alexander, Brian
    Awad, Mark M.
    Contessa, Joseph
    Chiang, Veronica
    Hardie, John
    Ma, Daniel
    Lou, Emil
    Sperduto, William
    Mehta, Minesh P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : 406 - 413
  • [44] Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status
    Liao, Chien-Yi
    Lee, Cheng-Chia
    Yang, Huai-Che
    Chen, Ching-Jen
    Chung, Wen-Yuh
    Wu, Hsiu-Mei
    Guo, Wan-Yuo
    Liu, Ren-Shyan
    Lu, Chia-Feng
    PHYSICAL AND ENGINEERING SCIENCES IN MEDICINE, 2023, 46 (02) : 585 - 596
  • [45] Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases
    Shao-bo Ke
    Hu Qiu
    Jia-mei Chen
    Wei Shi
    Yong-shun Chen
    Current Medical Science, 2018, 38 : 1062 - 1068
  • [46] Cytoplasmic ERβ1 expression is associated with survival of patients with Stage IV lung adenocarcinoma and an EGFR mutation at exon 21 L858R subsequent to treatment with EGFR-TKIs
    He, Cheng
    He, Yifu
    Luo, Huiqin
    Zhang, Ming
    Wu, Jing
    He, Xiaofang
    Fu, Yuying
    Chen, Wenju
    Zou, Jinkun
    ONCOLOGY LETTERS, 2019, 18 (01) : 792 - 803
  • [47] Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs
    Qi Gui
    Jiangang Liu
    Dapeng Li
    Chengcheng Xu
    World Journal of Surgical Oncology, 15
  • [48] Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs
    Gui, Qi
    Liu, Jiangang
    Li, Dapeng
    Xu, Chengcheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [49] Comparative Efficacy of Treatments for Brain Metastases from Non-Small Cell Lung Cancer without an EGFR-Mutation/ALK-Rearrangement: A Systematic Review and Network Meta-Analysis
    Brar, Karanbir
    Taslimi, Shervin
    Ellenbogen, Yosef
    Deng, Jiawen
    Hou, Winston
    Moraes, Fabio Y.
    Glantz, Michael
    Zacharia, Brad E.
    Tan, Aaron
    Ahluwalia, Manmeet S.
    Khasraw, Mustafa
    Zadeh, Gelareh
    Mansouri, Alireza
    WORLD NEUROSURGERY, 2022, 158 : E87 - E102
  • [50] Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study
    Yang, Xue-Ning
    Yan, Hong-Hong
    Wang, Jun
    Chu, Xiang-Yang
    Liu, Zhi-Dong
    Shen, Yi
    Ma, Hai-Tao
    Fu, Xiang-Ning
    Hu, Jian
    Zhou, Nai-Kang
    Liu, Yong-Yu
    Zhou, Xin-Ming
    Li, Jing-Song
    Yang, Kang
    Li, Jian
    Xu, Lin
    Wang, Si-Yu
    Wang, Qun
    Liu, Lun-Xu
    Xu, Shun
    Chen, Zhong-Yuan
    Lou, Hong-He
    Wang, Chang-Li
    Cheng, Ying
    Liu, Si-Yang
    Zhang, Xu-Chao
    Zhong, Wen-Zhao
    Wu, Yi-Long
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (01):